First-use risks.
作者信息
Rowe Timothy C
出版信息
CMAJ. 2003 May 27;168(11):1394.
Abstract
摘要
相似文献
1
First-use risks.首次使用风险。
CMAJ. 2003 May 27;168(11):1394.
2
Diane-35 (cyproterone acetate): safety concerns.达英-35（醋酸环丙孕酮）：安全性问题。
CMAJ. 2003 Feb 18;168(4):455-6.
3
Too much disclosure of product risks? CBC television, SOGC, and Diane-35.产品风险披露过多？加拿大广播公司电视台、加拿大妇产科医师学会和达英-35
J Obstet Gynaecol Can. 2003 Apr;25(4):268-9; discussion 270-3. doi: 10.1016/s1701-2163(16)31028-3.
4
Cyproterone acetate/ethinyl estradiol for acne and hirsutism: time to revise prescribing policy.醋酸环丙孕酮/炔雌醇治疗痤疮和多毛症：是时候修订处方政策了。
Hum Reprod. 2008 Feb;23(2):231-2. doi: 10.1093/humrep/dem379. Epub 2007 Dec 14.
5
Cyproterone acetate with ethinylestradiol as a risk factor for venous thromboembolism: an epidemiological evaluation.醋酸环丙孕酮与炔雌醇作为静脉血栓栓塞的危险因素：一项流行病学评估。
J Obstet Gynaecol Can. 2004 May;26(5):457-8.
6
The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.服用醋酸环丙孕酮联合炔雌醇的女性发生静脉血栓栓塞的风险：一项巢式队列分析和病例对照研究。
Hum Reprod. 2003 Mar;18(3):522-6. doi: 10.1093/humrep/deg120.
7
[Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge].
Ann Dermatol Venereol. 2013 Jun-Jul;140(6-7):474-8. doi: 10.1016/j.annder.2013.04.093. Epub 2013 May 31.
8
[Effects of an anti-androgen combination preparation on the hemostatic system].[一种抗雄激素联合制剂对止血系统的影响]
Fortschr Med. 1987 Jan 30;105(3):55-8.
9
[Oral contraceptives, risks and hazards].[口服避孕药，风险与危害]
Ann Dermatol Venereol. 2014 Jan;141(1):5-6. doi: 10.1016/j.annder.2013.12.001. Epub 2014 Jan 10.
10
Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.醋酸环丙孕酮联合炔雌醇（达英-35）相关的静脉血栓栓塞：使用英国全科医学研究数据库的观察性研究
Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):427-36. doi: 10.1002/pds.896.
本文引用的文献
1
Diane-35 (cyproterone acetate): safety concerns.达英-35（醋酸环丙孕酮）：安全性问题。
CMAJ. 2003 Feb 18;168(4):455-6.
2
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives.环丙孕酮或左炔诺孕酮避孕药导致静脉血栓栓塞的风险。
Lancet. 2001 Oct 27;358(9291):1427-9. doi: 10.1016/S0140-6736(01)06522-9.
3
First-time use of newer oral contraceptives and the risk of venous thromboembolism.新型口服避孕药的首次使用与静脉血栓栓塞风险
Contraception. 1997 Sep;56(3):141-6. doi: 10.1016/s0010-7824(97)00119-4.
Zotero 插件